Ratings Cross Country Healthcare, Inc.

Equities

CCRN

US2274831047

Market Closed - Nasdaq 04:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
17.4 USD -0.97% Intraday chart for Cross Country Healthcare, Inc. +1.58% -23.14%

Summary

  • The company has a good ESG score relative to its sector, according to Refinitiv.

Strengths

  • The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.37 for the 2024 fiscal year.
  • The company has a low valuation given the cash flows generated by its activity.
  • Historically, the company has been releasing figures that are above expectations.

Weaknesses

  • As estimated by analysts, this group is among those businesses with the lowest growth prospects.
  • The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • The company sustains low margins.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
  • Over the past four months, analysts' average price target has been revised downwards significantly.
  • Over the past twelve months, analysts' consensus has been significantly revised downwards.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Employment Services

1st Jan change Capi. Investor Rating ESG Refinitiv
-23.14% 609M
B+
-19.45% 8.8B
A-
-19.70% 7.39B
A-
-24.59% 5.73B
B+
-4.13% 3.73B
A-
-10.33% 3.16B
C+
+0.11% 1.52B -
+10.49% 1.5B -
-1.25% 1.47B -
-5.27% 1.2B
B-
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. CCRN Stock
  4. Ratings Cross Country Healthcare, Inc.